Recombinant LIV-1 (Ladiratuzumab Biosimilar) 抗体
This anti-LIV-1 (Ladiratuzumab Biosimilar) antibody is a Human 单克隆 antibody detecting LIV-1 (Ladiratuzumab Biosimilar) in . Suitable for 人.
Quick Overview for Recombinant LIV-1 (Ladiratuzumab Biosimilar) 抗体 (ABIN7666375)
抗原
LIV-1 (Ladiratuzumab Biosimilar)
抗体类型
Recombinant Antibody
适用
人
宿主
Human
克隆类型
单克隆
标记
This LIV-1 (Ladiratuzumab Biosimilar) antibody is un-conjugated
应用范围
请咨询
-
-
Expression System
- CHO Cells
-
原理
- SLC39A6 antibody (Ladiratuzumab biosimilar)
-
纯度
- ≥95 % (SDS-PAGE&SEC)
-
亚型
- IgG1
-
-
anti-LIV-1 (Ladiratuzumab Biosimilar) antibody
Research Grade 适用: 人 ELISA 宿主: Humanized Monoclonal unconjugated Recombinant Antibody
-
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
储存方法
- Please store the product under the recommended conditions in the the instructions.
-
-
- LIV-1 (Ladiratuzumab Biosimilar)
-
别名
- Ladiratuzumab biosimilar
-
物质类
- Biosimilar
-
背景
- Ladiratuzumab | SLC39A6
-
基因ID
- 25800
-
UniProt
- Q13433
抗原
-
You are here:
